Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02820207
Other study ID # (2016)003
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 13, 2016
Est. completion date June 30, 2020

Study information

Verified date July 2020
Source Beijing Tsinghua Chang Gung Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

OBJECTIVE/BACKGROUND: Intraplaque neovascularization is one of the most important risk factors for unstable carotid plaque. This study was designed to evaluate whether carotid intraplaque neovascularization (IPN) can be accurately assessed by contrast enhanced ultrasound (CEUS). METHODS: Preoperative CEUS analysis of 50 carotid artery stenosis patients would be compared to histopathology performed on their plaques excised by carotid endarterectomy (CEA) with CD34 and MMP9 staining.


Description:

1. To enroll 50 cases of patients suffering from carotid artery stenosis continuously, the investigators perform contrast enhanced ultrasound on patients for identifying the vulnerable plagues and taking high resolution MR inspection to analysis those plagues at the same time. 2. All patients undergo carotid endarterectomy. The vulnerable ingredients of carotid plaques such as intraplaque neovascularization and bleeding are identified by pathological examination and immunohistochemical staining. 3. To evaluate the accuracy of CEUS for identifying carotid vulnerable plague compared with high resolution MR. 4. The investigators divide patients into the stable group and the vulnerable group based on the results of CEUS inspection. To analysis the incidence of postoperative complications such as stroke and mortality within 30 days and to compare the differences between the two groups.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date June 30, 2020
Est. primary completion date November 30, 2019
Accepts healthy volunteers No
Gender All
Age group 50 Years to 80 Years
Eligibility Inclusion Criteria: - The patients with ischemic symptom whose carotid stenosis were more than 50% - The patients without ischemic symptom whose carotid stenosis were more than 70% Exclusion Criteria: - Confirmed with severe intracranial vascular lesions - Suffering from the large area cerebral infarction or critical stroke sequela - Restenosis after CEA or CAS - Suffering from severe coronary heart disease, respiratory failure,the hypertension difficult to controled - Patients with malignant tumor or expected life < 2 years

Study Design


Locations

Country Name City State
China Beijing Tsinghua Chang Gung Hosipital Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Beijing Tsinghua Chang Gung Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary the incidence of ischemia shock The incidence of ischemic stroke was defined as the number of cases of postoperative cerebral infarction divided by the total number of cases within 30 days after operations
Secondary the incidence of restenosis the loss of lumen of carotid beyond 70% is defined as restenosis 6 months after operations
Secondary the incidence of all-cause mortality All-cause mortality includes all causes of death, such as MI, heart failure, stroke, bleeding et al. within 30 days after operations
See also
  Status Clinical Trial Phase
Completed NCT02224339 - New Technologies to Determine Carotid Plaque Vulnerability
Recruiting NCT05549336 - Single-center, Prospective Cohort Study of PD-1 Inhibitors on Clinical Outcomes of Carotid Plaques in Tumor Patients
Recruiting NCT05123287 - A Perspective, Self-control Study on the Progression of Carotid Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up
Recruiting NCT04679727 - The Carotid Artery Multi-modality Imaging Prognostic (CAMP) Study
Recruiting NCT02476396 - Structural Stability of Carotid Plaque and Symptomatology
Completed NCT02947360 - The FOVUS-ER Study: Focused Vascular Ultrasound to Risk Stratify Patients With Chest Pain in the ER N/A
Completed NCT03335033 - New Technologies to Determine Carotid Plaque Vulnerability in Patients With Significant Carotid Plaques Phase 2
Recruiting NCT05029661 - Ultrasound Elastography for Individual Carotid Plaque Stratification
Not yet recruiting NCT05622877 - The Proteomic Study and Early Intervention Study of Carotid Unstable Plaque Phase 1
Not yet recruiting NCT03072225 - Study on Vulnerable Plaque of Carotid Artery With Chinese Herbal and Insects Medicine Phase 2
Recruiting NCT04073797 - PET Imaging of Inflammation and Lipid Lowering Study N/A
Recruiting NCT04470687 - Ultrafast Ultrasound Imaging Assesment of Carotid Plaque Neovascularization N/A
Completed NCT05566080 - Preoperative Identification of the Histologically "Vulnerable" Plaque Using Non-invasive Imaging, Biomechanical Assessment and Baroreflex Evaluation in Patients With Severe Carotid Stenosis
Active, not recruiting NCT04913493 - Use of Sublingual Microcirculation and FloTrac Monitoring During Major Vascular Surgery and Its Effect on Hospital LOS N/A
Completed NCT03982420 - The ENROUTE Transcarotid Neuroprotection System (ENROUTE Transcarotid NPS) DW-MRI Evaluation
Completed NCT05134493 - Embolic Signals Detection Study (Esds) in Candidates for Surgical Carotid Revascularisation
Terminated NCT02667457 - 99mTc-rhAnnexin V-128 Imaging for Carotid Atherosclerosis Phase 2
Recruiting NCT04063709 - Transcutaneous ARFI Ultrasound for Differentiating Carotid Plaque With High Stroke Risk N/A
Completed NCT04318171 - The Evaluation of Tomographic 3D Ultrasound for the Assessment of Vascular Pathology
Completed NCT04835571 - CARotid Mri of Atherosclerosis N/A